{"filing":{"accession_number":"0001096906-26-001117","cik":"0001630176","ticker":"HYEX","company_name":"HEALTHY EXTRACTS INC.","form":"8-K","filing_date":"2026-07-23","report_date":"2026-07-17","primary_document":"hyex-20260717_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1630176/000109690626001117/hyex-20260717_8k.htm"},"events":[{"id":20222,"run_id":18207,"accession_number":"0001096906-26-001117","anchor_item_number":"1.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"HYEX entered into a Securities Purchase Agreement with LABRYS FUND II, L.P. to issue a convertible promissory note with $258,750 principal (net proceeds $225,000) convertible into common stock at the lesser of $2.00 per share or 75% of the lowest closing bid price during the preceding 15 trading days, together with an unregistered sale of equity securities under Section 4(a)(2) of the Securities Act to an accredited investor. This private placement creates significant dilution potential for existing shareholders.","company_name":"HEALTHY EXTRACTS INC.","ticker":"HYEX","filing_date":"2026-07-23","form":"8-K","submitted_at":null,"items":[{"id":19523,"accession_number":"0001096906-26-001117","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The filing discloses entry into a Securities Purchase Agreement whereby HYEX issued a convertible promissory note to LABRYS FUND II, L.P. for $258,750 principal (net proceeds $225,000). The note is convertible into common stock at a price of the lesser of $2.00 per share or 75% of the lowest closing bid price during the preceding 15 trading days, creating significant dilution potential. This is a material capital-raising transaction typical of small-cap issuers raising cash through convertible debt with equity kickers.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T10:03:46.218266+00:00","company_name":"","ticker":null,"filing_date":""},{"id":19524,"accession_number":"0001096906-26-001117","item_number":"3.02","item_title":"Unregistered Sale of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 3.02 discloses an unregistered sale of equity securities under Section 4(a)(2) of the Securities Act. The disclosure references a Securities Purchase Agreement involving a convertible note and common stock issued upon conversion, sold to an accredited investor. This is a classic private placement of equity securities with dilutive potential, fitting the dilutive_issuance category. The unregistered nature and reliance on a securities law exemption are hallmarks of this event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T10:03:46.218266+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":19523,"accession_number":"0001096906-26-001117","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The filing discloses entry into a Securities Purchase Agreement whereby HYEX issued a convertible promissory note to LABRYS FUND II, L.P. for $258,750 principal (net proceeds $225,000). The note is convertible into common stock at a price of the lesser of $2.00 per share or 75% of the lowest closing bid price during the preceding 15 trading days, creating significant dilution potential. This is a material capital-raising transaction typical of small-cap issuers raising cash through convertible debt with equity kickers.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T10:03:46.218266+00:00","company_name":"HEALTHY EXTRACTS INC.","ticker":"HYEX","filing_date":"2026-07-23"},{"id":19524,"accession_number":"0001096906-26-001117","item_number":"3.02","item_title":"Unregistered Sale of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 3.02 discloses an unregistered sale of equity securities under Section 4(a)(2) of the Securities Act. The disclosure references a Securities Purchase Agreement involving a convertible note and common stock issued upon conversion, sold to an accredited investor. This is a classic private placement of equity securities with dilutive potential, fitting the dilutive_issuance category. The unregistered nature and reliance on a securities law exemption are hallmarks of this event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T10:03:46.218266+00:00","company_name":"HEALTHY EXTRACTS INC.","ticker":"HYEX","filing_date":"2026-07-23"}]}